Hansoh Pharmaceutical's (HKG:3692) obtained clinical trial approval for its HS-10541 tablets from China's National Medical Products Administration, according to a Wednesday Hong Kong bourse filing.
Shares of the pharma firm were down over 1% in Thursday afternoon trading.
The trial will study the drug for the treatment of patients with KRAS G12C-mutated advanced solid tumors.
Chinese President Xi Jinping said Beijing and Washington's economic teams reached a "generally balanced and positive outcome" during Wednesday's meeting, Xinhua News Agency reported Thursday.Xi made the remarks after welcoming U.S. President Donald Trump in Beijing.U.S. Treasury Secretary Scott Bessent and Chinese Vice Premier He Lifeng met in South Korea on Wednesday, ahead of the high-stakes meeting on Thursday, the BBC reported."Facts have repeatedly proven that there are no winners in a trade war, and the essence of China-US economic and trade relations is mutual benefit and win-win cooperation," Xinhua quoted Xi as saying.
Rua Gold (NZE:RGI) reported Thursday a loss of CA$0.05 per share for the March quarter, unchanged from a year earlier.The exploration-stage mining company did not report any revenue for the quarter.
China's National Association of Financial Market Institutional Investors accepted Shaanxi Provincial Natural Gas' (SHE:002267) application to issue medium-term bonds of up to 2 billion yuan, according to a Shenzhen bourse filing on Thursday.The registration quota is valid for two years.